<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01223391</url>
  </required_header>
  <id_info>
    <org_study_id>10-005203</org_study_id>
    <nct_id>NCT01223391</nct_id>
  </id_info>
  <brief_title>Abdominal Compression in Orthostatic Hypotension</brief_title>
  <official_title>The Efficacy of Adjustable Lower Abdominal Compression in Neurogenic Orthostatic Hypotension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess if abdominal binders that use pull strings to adjust&#xD;
      compression (non-elastic) are more effective than standard elastic abdominal binders in&#xD;
      attenuating neurogenic orthostatic hypotension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In 3 protocols, patients will undergo standing maneuvers, measured abdominal compressions,&#xD;
      continuous BP monitoring and symptoms, ease-of-use and compliance scoring. In protocol 1,&#xD;
      patients will exert abdominal compression to maximal tolerable and comfortable levels and&#xD;
      values will be recorded. In protocol 2, patients will perform 3 standing maneuvers following&#xD;
      a preceding rest period with and without abdominal compression at 20 mmHg (binders used in&#xD;
      random order). In protocol 3, the standing maneuvers will be extended and the investigator&#xD;
      will adjust binders to levels of abdominal compression corresponding to what patient gauged&#xD;
      as maximal tolerable and comfortable levels. Comparison of outcome measures will establish&#xD;
      which binder achieves higher abdominal compression, is easier to adjust, likely will be used&#xD;
      in the future, if elastic and adjustable binders are equally effective in attenuating&#xD;
      Orthostatic Hypotension and its associated symptoms at comparable pressures and which binder&#xD;
      is more effective in recovering standing BP and improving orthostatic symptoms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference between averaged standing blood pressure with and without binders</measure>
    <time_frame>3-7 minutes</time_frame>
    <description>A 1-minute averaged blood pressure is measured at 3 minutes of standing without abdominal binder and at 3, 4.5 and 6.5 minutes of standing with abdominal binders. All measurements are obtained during a single session.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in orthostatic symptom score with and without binders</measure>
    <time_frame>3-7 minutes</time_frame>
    <description>Orthostatic symptoms are measured at 3 minutes of standing without abdominal binder, and at 3, 4.5 and 6.5 minutes of standing with abdominal binders. All measurements are obtained during a single session.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Autonomic Failure</condition>
  <condition>Orthostatic Hypotension</condition>
  <arm_group>
    <arm_group_label>Abdominal binder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standing with abdominal compression using elastic vs. non-elastic abdominal binders.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No abdominal binder</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standing without abdominal compression</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Abdominal binder</intervention_name>
    <description>External abdominal compression sequentially applied at 20 mmHg for 3 minutes, maximal tolerable level for 1.5 minutes and comfortable level for 2 minutes.</description>
    <arm_group_label>Abdominal binder</arm_group_label>
    <other_name>Elastic abdominal binder</other_name>
    <other_name>Non-elastic abdominal binder</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No abdominal binder</intervention_name>
    <description>Standing without abdominal binder for 3 minutes</description>
    <arm_group_label>No abdominal binder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        SUBJECTS We will study 15 patients of both genders with neurogenic orthostatic hypotension&#xD;
        (OH). Subjects will be recruited from the existing list of patients available in the&#xD;
        database of the Autonomic Disorders Center.&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          1. Men and nonpregnant women aged 18-80 years.&#xD;
&#xD;
          2. Chronic neurologic conditions known to cause OH: multiple system atrophy (MSA),&#xD;
             Parkinson's disease, autoimmune autonomic ganglionopathy or progressive autonomic&#xD;
             neuropathy (e.g., diabetic, amyloid).&#xD;
&#xD;
          3. Orthostatic hypotension defined as a drop of systolic BP&gt;30 mmHg or diastolic BP&gt;15&#xD;
             mmHg.&#xD;
&#xD;
          4. Adrenergic failure of at least moderate severity defined as CASS-adrenergic â‰¥3.&#xD;
&#xD;
          5. Ambulatory and able to stand more than 3 minutes without pre-syncope.&#xD;
&#xD;
          6. BMI &lt;29.&#xD;
&#xD;
          7. Ability to comply with study procedures and appointments.&#xD;
&#xD;
          8. Normal cognition (able to understand the study, learn the maneuvers, and follow&#xD;
             complex commands).&#xD;
&#xD;
          9. Concomitant therapy with anticholinergic, alpha and beta agonists will be withdrawn 48&#xD;
             hours prior to autonomic evaluations. Midodrine will be withdrawn the night before&#xD;
             evaluation. Fludrocortisone doses up to 0.2 mg per day will be permitted.&#xD;
&#xD;
        The diagnosis of probable MSA requires 1) the presence of orthostatic hypotension or&#xD;
        urinary incontinence, and 2) poorly levodopa responsive parkinsonism or cerebellar ataxia.&#xD;
&#xD;
        The diagnosis of clinically definite Parkinson's disease requires 1) the presence of&#xD;
        resting tremor, bradykinesia and rigidity, 2) clinical asymmetry, and 3) response to&#xD;
        levodopa.&#xD;
&#xD;
        The diagnosis of autoimmune autonomic ganglionopathy requires 1) a sub-cute onset, 2) the&#xD;
        presence of generalized and severe autonomic failure (CASS&gt;6), 3) selective involvement of&#xD;
        autonomic nerve fibers and 4) positive alpha-3 nicotinic acetylcholine receptor&#xD;
        auto-antibodies.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Pregnant or lactating females.&#xD;
&#xD;
          2. Non-neurogenic OH, such as that due to medication or hypovolemia.&#xD;
&#xD;
          3. Chronic illnesses or other central nervous system conditions that affect autonomic&#xD;
             function.&#xD;
&#xD;
          4. Established dementia.&#xD;
&#xD;
          5. Debilitating ataxia.&#xD;
&#xD;
          6. Moderate to severe lower extremity weakness.&#xD;
&#xD;
          7. Severe systemic illness, such as end-stage pulmonary, cardiac or renal disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Basford, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <study_first_submitted>September 28, 2010</study_first_submitted>
  <study_first_submitted_qc>October 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2010</study_first_posted>
  <last_update_submitted>May 9, 2014</last_update_submitted>
  <last_update_submitted_qc>May 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2014</last_update_posted>
  <responsible_party>
    <name_title>Jeffrey Basford, MD, PhD</name_title>
    <organization>Mayo Clinic</organization>
  </responsible_party>
  <keyword>orthostatic</keyword>
  <keyword>abdominal compression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension, Orthostatic</mesh_term>
    <mesh_term>Pure Autonomic Failure</mesh_term>
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

